SNES

SenesTech Inc
NASDAQBASIC MATERIALSSPECIALTY CHEMICALS

Key Statistics

Market Cap
$6.21M
P/E Ratio
—
EPS
$-1.22
Beta
0.11
52W High
$3.61
52W Low
$0.55
50-Day MA
$0.85
200-Day MA
$1.46
Dividend Yield
—
Profit Margin
-294.70%
Forward P/E
3.40
PEG Ratio
-0.06

About SenesTech Inc

SenesTech, Inc. develops a technology for managing animal pest populations by controlling fertility. The company is headquartered in Phoenix, Arizona.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.37M
Gross Profit (TTM)$1.57M
EBITDA$-7.09M
Operating Margin-241.80%
Return on Equity-107.40%
Return on Assets-45.60%
Revenue/Share (TTM)$0.46
Book Value$1.14
Price-to-Book1.05
Price-to-Sales (TTM)2.61
EV/Revenue1.619
EV/EBITDA0.11
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)23.20%
Shares Outstanding$5.30M
Float$2.43M
% Insiders14.71%
% Institutions49.90%

Historical Volatility

HV 10-Day
123.02%
HV 20-Day
106.33%
HV 30-Day
114.86%
HV 60-Day
92.42%
HV Rank
91.3%

Volatility is currently expanding

Analyst Ratings

Consensus ($7.50 target)
1
Buy

Latest News

SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue

SURPRISE, Ariz., Oct. 22, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that, on Oct. 20, 2026, it received a letter from the listing qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price of its common stock had been below $1.00 per share for 30 consecutive business days. As a result, the Company does not currently meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

GlobeNewsWire10/22/2026Neutral
GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH

Glenbrook Believes Better Market Strategy and Sharpened Capitalization Focus Would Create Significant Upside MINDEN, Nev., Oct. 19, 2026 /PRNewswire/ -- Glenbrook Capital Management ("Glenbrook"), a long-time shareholder of SenesTech, Inc. (NASDAQ: SNES) (the "Company") and owners of over 30% of outstanding shares of the Company, today issued the following letter.

PRNewsWire10/19/2026Neutral
SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone

Rodent-Related 311 Calls in Deployment Area Fell 36% While Citywide Calls Increased Evolve® Rat Bith Control TM Expands to Six Chicago-Area SSAs and Wards SURPRISE, Ariz., Oct. 19, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced results from a pilot of Evolve® Rat Birth Control™ in Chicago's Wicker Park Bucktown Special Service Area (SSA) #33.

GlobeNewsWire10/19/2026Neutral
SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference

PHOENIX, Sept. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

PRNewsWire9/17/2026Neutral
Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat

SURPRISE, Ariz., Aug. 31, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deployment of Evolve® Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts.

PRNewsWire8/31/2026Neutral
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.

PRNewsWire8/27/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SNES and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More BASIC MATERIALS Stocks

Data last updated: 11/7/2026